Skip to content
Search

Latest Stories

GPhC removes pharmacy technician over 'possession of indecent photographs of children'

The General Pharmaceutical Council (GPhC) Fitness to Practise Committee has removed a pharmacy technician from Register after been found guilty of possessing ‘indecent photographs of a child’.

Graeme Arthur, a pharmacy technician first registered with GPhC on 1 September 2019, under the registration number 5039154, was found guilty at Peterlee Magistrate’s Court in August 2022. He received an 18-month Community Order, and is subject to a Sexual Harm Prevention Order for 5 years. He was also ordered to undertake a period of rehabilitation activity for 40 days.


In a remote video link hearing held on 2 – 3 May, the Fitness to Practise Committee found Arthur’s fitness to practise to be currently impaired on grounds of protection of the public and in the wider public interest of declaring and upholding the Standards of the profession and maintaining public confidence in the reputation of the profession.

The committee considers this to be a serious conviction for an offence which has included possession of the most serious category of images of sexual abuse of children.

It said: “Although Mr Arthur had no direct contact with the children concerned, the nature of the abuse is that it thrives on the demand from those who search for and view the images online. As such, children come to actual harm indirectly through the activity of someone viewing and possession of images of sexual abuse.”

It added: “…However, the Pre-Sentence Report from the Probation Service found that he remained at “medium risk” of further offending for possessing or downloading of indecent images of children. He has not yet completed his 40 days of rehabilitation activity and his sentence includes a Sexual Harm Prevention Order for a period of 5 years, which continues until 2027.

“The Safer Lives Report dated 6 April 2022 concludes that the programme of work undertaken “represents a start for Mr Arthur to begin to understand, challenge and change his behaviours.” For all of the above reasons, we conclude that Mr Arthur continues to present a potential risk to patients or the public.”

On Monday 10th January 2022, Police attended the home address of Arthur and seized digital equipment in relation to an investigation for possessing indecent images of children.

Following a forensic examination of Arthur’s mobile phone, the Forensic Examiner identified three Category A images, two Category B images and two Category C images.

Police conducted a voluntary interview with Arthur on 14 January 2022 in relation to the offence of possessing indecent images of children. At the beginning of the interview, Arthur denied the offence but, further into the interview he made admissions. On 08 July 2022, Arthur was charged with the possession of indecent images across three categories.

The Council decision will not take effect until 31 May 2023 or, if an appeal is lodged, once that appeal has been concluded. However, the interim suspension set out in the decision takes effect immediately and will lapse when the decision takes effect or once any appeal is concluded.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less